B Allione
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Acute Myeloid Leukemia Research 2
- Multiple Myeloma Research and Treatments 2
- Genetics 3
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Alessandro CignettiAlessandro VitaleEM BryantRobin FoàMartin A. CheeverAlessandro LevisAnna BaraldiDaniela Cilloni
- Journals
- Blood (2 papers)Hematological Oncology (1 paper)Journal of Clinical Oncology (1 paper)Leukemia Research (1 paper)Leukemia (1 paper)
- Partner nations
- ItalyUnited StatesFinland
In The Last Decade
B Allione
9 papers receiving 270 citations
Peers
Comparison fields: 5 of 33
- Hematology 119
- Genetics 60
- Immunology 114
- Oncology 105
- Pathology and Forensic Medicine 57
Countries citing papers authored by B Allione
This map shows the geographic impact of B Allione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Allione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Allione more than expected).
Fields of papers citing papers by B Allione
This network shows the impact of papers produced by B Allione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Allione. The network helps show where B Allione may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B Allione, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 0 | |
| 2 | 2017 | 54 | |
| 3 | 2015 | 2 | |
| 4 | 2008 | 59 | |
| 5 | 2007 | 1 | |
| 6 | LIMITED GRAFT-VERSUS MYELOMA EFFECT AFTER LOW-DOSE TBI BASED NON-MYELOABLATIVE ALLOGRAFTING EMPLOYED AS SALVAGE TREATMENT COMPARED TO FIRST LINE TREATMENT | 2006 | 0 |
| 7 | 2001 | 14 | |
| 8 | Unsuccessful treatment of resistant thrombotic thrombocytopenic purpura with prostacyclin. | 2000 | 3 |
| 9 | Low-dose of thalidomide in the treatment of refractory myeloma. | 2000 | 21 |
| 10 | 1999 | 5 | |
| 11 | 1999 | 114 |
About B Allione
B Allione is a scholar working on Hematology, Genetics, Oncology, Immunology and Neurology, having authored 11 papers that have together received 273 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Neutropenia and Cancer Infections (2 papers), Viral-associated cancers and disorders (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), Multiple Myeloma Research and Treatments (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Hematology (119 citations), Genetics (60 citations), Immunology (114 citations), Oncology (105 citations) and Pathology and Forensic Medicine (57 citations). B Allione has collaborated with scholars based in Italy, United States and Finland. Frequent co-authors include Alessandro Cignetti, Alessandro Vitale, EM Bryant, Robin Foà, Martin A. Cheever, Alessandro Levis, Anna Baraldi, Daniela Cilloni, Daniela Gioia and Daniela Pietrasanta. Their work appears in journals such as Blood, Hematological Oncology, Journal of Clinical Oncology, Leukemia Research and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.